Moreover, SSTR expression was not associated with clinical characteristics, Ki67 proliferative index, or clinical outcome, suggesting that the expression of SSTR is not itself a favorable prognostic index in MCC, differently from other neuroendocrine tumors. This evidence concerns the gene MKI67 and neuroendocrine neoplasm.